Harry Cassin
Publisher and Editor
Andy Spalding
Senior Editor
Jessica Tillipman
Senior Editor
Bill Steinman
Senior Editor
Richard L. Cassin
Editor at Large
Elizabeth K. Spahn
Editor Emeritus
Cody Worthington
Contributing Editor
Julie DiMauro
Contributing Editor
Thomas Fox
Contributing Editor
Marc Alain Bohn
Contributing Editor
Bill Waite
Contributing Editor
Shruti J. Shah
Contributing Editor
Russell A. Stamets
Contributing Editor
Richard Bistrong
Contributing Editor
Eric Carlson
Contributing Editor
American pharmaceuticals giant Pfizer disclosed this month that the DOJ and SEC’s investigation into possible FCPA violations has expanded to Mexico, the third county named so far.… Continue Reading
The New York-headquartered biopharmaceutical giant paid the DOJ and SEC $60 million in 2012 to settle FCPA offenses in Bulgaria, Croatia, China, Czech Republic, Italy, Kazakhstan, Russia, Serbia, Indonesia, Pakistan, and Saudi Arabia.… Continue Reading
The World Bank’s enforcement arm, the Integrity Vice Presidency (INT), signaled this month they are mirroring initiatives first put forth by U.S. law enforcement. Specifically, INT indicated that they are investing significant resources into formally evaluating companies’ compliance programs during an investigation.… Continue Reading
Murdered Slovak journalist Jan Kuciak (credit Aktuality.sk)A 27-year-old Slovak reporter and his fiancée were murdered in their home in late February. It looked like a professional hit.
The journalist, Jan Kuciak, was working on an investigation for the Slovak news portal Aktuality.sk,… Continue Reading
Developing countries are losing between $20 billion to $40 billion every year, making graft the greatest obstacle to economic and social development around the world, according to a report released this month by the United Nations Office on Drugs and Crime (UNODC).… Continue Reading
A subsidiary of Pfizer Inc. agreed with the DOJ today to pay a $15 million criminal penalty to resolve FCPA violations in Bulgaria, Croatia, Kazakhstan, and Russia.
Pfizer also agreed with the SEC to pay $26.3 million in disgorgement of profits and pre-judgment interest to settle civil charges.… Continue Reading
U.K.-based pharma AstraZeneca said its office in Belgrade, Serbia was served with a criminal indictment ‘relating to allegations that local employees . . . made allegedly improper payments to physicians at the Institute of Oncology and Radiology of Serbia.’ … Continue Reading
